The latest news from academia, regulators
research labs and other things of interest
Posted: May 6, 2009
NanoBio to Announce Key Preclinical Data on Topical Anti-infective Lotions
(Nanowerk News) NanoBio Corporation announced today that it will present compelling new data highlighting preclinical milestones in the development of its novel topical treatments for acne and fungal infections. The new data will be delivered in three poster presentations during the 2009 annual meeting of the Society of Investigative Dermatology in Montreal, Canada, from May 6-9, 2009.
- Poster # 616: In-vitro Susceptibility of Propionibacterium acnes and Skin Penetration of NB-00X Formulations
Saturday, May 9, 2009
- Poster # 465: Lateral Diffusion of Terbinafine Hydrochloride in a Novel Nanoemulsion
NanoBio® Corp. is a privately held biopharmaceutical company focused on developing and commercializing dermatological products, anti-infective treatments and intranasal vaccines derived from its patented NanoStat™ technology platform. The company’s lead product candidates are treatments for herpes labialis (cold sores), onychomycosis (nail fungus), acne, cystic fibrosis and a broad platform of intranasal vaccines.